Page last updated: 2024-08-23

raloxifene hydrochloride and leucine

raloxifene hydrochloride has been researched along with leucine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abrams, J; Deighton-Collins, S; Koide, A; Koide, S; Martinez, A; Schwartz, JA; Skafar, DF; Zhao, C1
Asanuma, H; Beppu, S; Hori, M; Ishikura, F; Kitakaze, M; Liao, Y; Minamino, T; Node, K; Ogita, H; Sanada, S; Takashima, S1
Auger, A; Cotnoir-White, D; Dayan, G; Hébert, E; Hilmi, K; Jeyakumar, M; Katzenellenbogen, J; Loch, C; Lupien, M; Mader, S; Moras, D; Pinard, GA; Wurtz, JM1
Baxter, RC; Birzniece, V; Gibney, J; Ho, KK; Johannsson, G; Meinhardt, U; Seibel, MJ1

Trials

1 trial(s) available for raloxifene hydrochloride and leucine

ArticleYear
Modulatory effect of raloxifene and estrogen on the metabolic action of growth hormone in hypopituitary women.
    The Journal of clinical endocrinology and metabolism, 2010, Volume: 95, Issue:5

    Topics: Adult; Calorimetry, Indirect; Cross-Over Studies; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Human Growth Hormone; Humans; Hypopituitarism; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Leucine; Middle Aged; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators

2010

Other Studies

3 other study(ies) available for raloxifene hydrochloride and leucine

ArticleYear
Mutation of Leu-536 in human estrogen receptor-alpha alters the coupling between ligand binding, transcription activation, and receptor conformation.
    The Journal of biological chemistry, 2003, Jul-18, Volume: 278, Issue:29

    Topics: Amino Acid Substitution; Base Sequence; Binding Sites; DNA; Estradiol; Estrogen Receptor alpha; Fulvestrant; HeLa Cells; Humans; In Vitro Techniques; Leucine; Ligands; Models, Molecular; Mutagenesis, Site-Directed; Promoter Regions, Genetic; Protein Conformation; Raloxifene Hydrochloride; Receptors, Estrogen; Tamoxifen; Transcription Factor AP-1; Transcriptional Activation; Two-Hybrid System Techniques

2003
Raloxifene prevents cardiac hypertrophy and dysfunction in pressure-overloaded mice.
    Hypertension (Dallas, Tex. : 1979), 2004, Volume: 43, Issue:2

    Topics: Animals; Constriction; Echocardiography; Hemodynamics; Hypertrophy, Left Ventricular; Leucine; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Myocardium; Myocytes, Cardiac; Pressure; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators

2004
Raloxifene and ICI182,780 increase estrogen receptor-alpha association with a nuclear compartment via overlapping sets of hydrophobic amino acids in activation function 2 helix 12.
    Molecular endocrinology (Baltimore, Md.), 2007, Volume: 21, Issue:4

    Topics: Amino Acid Motifs; Amino Acid Sequence; Amino Acid Substitution; Amino Acids; Cell Nucleus; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Fulvestrant; Humans; Leucine; Molecular Sequence Data; Mutation; Protein Structure, Secondary; Raloxifene Hydrochloride; Solubility; Transcription, Genetic; Trefoil Factor-1; Tumor Cells, Cultured; Tumor Suppressor Proteins

2007